Abridge

Abridge is the default AI clinical documentation tool for major health systems — Kaiser, UPMC, Mayo, Sutter, Yale. The outcome data on physician time-savings is real and well-documented.

Abridge's product is straightforward: physicians use a phone or wearable during patient visits, and Abridge produces structured clinical notes ready for EHR review. The differentiation versus Nuance DAX (Microsoft) and Suki is depth of integration with Epic and Cerner, breadth of specialty-tuned models (50+), and customer outcome data that has been independently validated by major health systems. UPMC and Kaiser have published time-saved metrics that survive scrutiny — physician documentation time down 30-60%, burnout scores improved.

The market position is the strongest in healthcare AI right now. Abridge has crossed the chasm from "promising AI scribe" to "the default Epic-recommended option for AI documentation," which compounds in healthcare procurement. The Series E at $2.75B reflects this momentum; the customer logo list reflects it more concretely.

The trade-offs are price ($300-600/clinician/month is real money for any system with thousands of clinicians) and dependency on EHR integration depth. For health systems on Epic or Cerner, this works. For smaller EHRs or non-integrated specialty practices, value drops sharply. Buy Abridge if you're a health system on Epic or Cerner with a real physician burnout problem and budget for $5M-$50M/year. Evaluate Nuance DAX if you're deeply Microsoft-aligned. Skip if you're solo or small-practice — value doesn't scale down well.